ACEA Biosciences Company Profile

17:01 EDT 19th September 2018 | BioPortfolio

ACEA Biosciences, founded in 2002, is a privately held biotechnology company located in San Diego, California. ACEA is developing a broad biosensor platform based on proprietary microelectronic technologies for reporterless, real time, high throughput analysis of living cells and biomolecules. ACEA's products are designed to meet the increasing needs of the life science research and drug discovery markets by providing automated, high content, real time analysis systems that simplify complex cell-based assay procedures and increase productivity. ACEA has launched its first product, a real time electronic sensing (RT-CES™) system based on direct microelectronic detection and readout of cell-based assay processes.


11585 Sorrento Valley Rd., Suite 103
San Diego
United States of America


Phone: (858) 724-0928
Fax: (858) 724-0927
Email: .,

News Articles [671 Associated News Articles listed on BioPortfolio]

ACEA launches comprehensive and searchable online library of xCELLigence papers

In 2002 ACEA Biosciences pioneered real-time cellular impedance as a tool for dynamically tracking cell number, cell size, cell-substrate attachment strength, and cell invasion/migration.

ACEA goes live with exhaustive, searchable library of NovoCyte publications

With the 2014 release of its NovoCyte flow cytometer ACEA Biosciences delivered a highly innovative instrument at an extremely competitive price point. In the ensuing three years features such as auto...

ACEA Biosciences Introduces an Exploratory xCELLigence® RTCA S16 Instrument

The new 16-well model uses a proprietary noninvasive biosensor technology to quantify cell proliferation, morphology changes, and adhesion in a label-free, real-time manner. SAN DIEGO (PRWEB) July 31,...

New High Performance 4-Laser Benchtop Flow Cytometer to be Launched by ACEA Biosciences at CYTO 2018

The NovoCyte Quanteon™ flow cytometer, a highly advanced benchtop instrument with 4 lasers and 25-color options, will be launched at CYTO 2018 SAN DIEGO (PRWEB) May 01, 2018 Continuing its track re...

Study uses ACEA Biosciences’ xCELLigence assay to monitor disruption of S. aureus biofilms

Biofilms are surface-attached communities of bacterial or fungal cells that are enmeshed in an extensive extracellular matrix which makes them more resistant to both antibiotics and the immune system.

ACEA Biosciences Partners with the Cancer Research Institute in Support of Cancer Immunotherapy Month

To promote the Cancer Research Institute’s global awareness campaign, Cancer Immunotherapy Month, ACEA Biosciences will be participating in the #WearWhite campaign on June 15 and providing an Immuno...

Novel xCELLigence Study of Acinetobacter baumannii Biofilms Receives Award

Doctoral candidate using real-time impedance monitoring to elucidate key biofilm genes awarded a travel grant by ACEA Biosciences SAN DIEGO, Calif. (PRWEB) July 17, 2018 By using the xCELLigence inst...

ASC Biosciences, Inc. announces ad dates for first television commercial

About ASC Biosciences, Inc.ASC Biosciences, Inc. ("ASC" or the "Company") is a development stage biotechnology company with a proprietary adult stem cell platform capable Read more...

Drugs and Medications [13 Associated Drugs and Medications listed on BioPortfolio]

Naturally nova scotia hand sanitizer [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Natelle one [Azur Pharma, Inc.]

Natelle OneRx Prenatal Vitamin & Plant-Based DHA Now with 28 mg Iron

Natelle one [Azur Pharma, Inc.]

Natelle®OneRx Prenatal Vitamin & Plant-Based DHA

PubMed Articles [59 Associated PubMed Articles listed on BioPortfolio]

Acellular Cauda Equina Allograft as Main Material Combined with Biodegradable Chitin Conduit for Regeneration of Long-Distance Sciatic Nerve Defect in Rats.

Autologous nerve grafting (ANG), the gold standard treatment for peripheral nerve defects, still has many restrictions. In this study, the acellular cauda equina allograft (ACEA), which consists of bi...


Back cover.

Contents list.

Front cover.

Clinical Trials [7 Associated Clinical Trials listed on BioPortfolio]

HepaStem Long-Term Safety Registry

All patients having received at least one infusion of the Investigational Medicinal Product (IMP) HepaStem HHALPC during a previous interventional clinical study conducted by Promethera Bi...

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

The purpose of this research is to determine if a subject's own bone marrow tissue can help regenerate bone in the area of his/her jaw where a tooth has been removed using Tissue Repair Ce...

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data

We seek to improve the predictive accuracy of the nomogram to predict survival for patients with castrate mets disease through the addition of pathological data, the results of automated m...

Validation of Decipher Test in African American Men With Prostate Cancer - VANDAAM

The primary purpose of this study is to determine whether a tumor test recently developed by GenomeDx Biosciences known as Decipher® can predict aggressive prostate cancer with the same a...

Individual Patient Expanded Access for AB-SA01, an Investigational Anti-Staphylococcus Aureus Bacteriophage Therapeutic

The purpose of the expanded access program is to allow physicians to provide treatment with investigational drug, AB-SA01, for patients with serious or immediately life-threatening Staphyl...

Companies [363 Associated Companies listed on BioPortfolio]

ACEA Biosciences, Inc.

Founded in 2002, ACEA Biosciences is a pioneer in the development and commercialization of high performance, cutting edge cell analysis platforms for life science research. ACEAâ...

ACEA Biosciences

ACEA Biosciences, founded in 2002, is a privately held biotechnology company located in San Diego, California. ACEA is developing a broad biosensor platform based on proprietary microelectronic techno...

Hydra Biosciences, Inc.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other diseases using...

Leadiant Biosciences, Inc.

Leadiant Biosciences, Inc. (formerly Sigma-Tau Pharmaceuticals, Inc.) is a U.S.-based, wholly owned subsidiary of Leadiant Biosciences S.p.A., a research-based pharmaceutical comp...

JeNu Biosciences

JeNu Biosciences was founded in 2008 by a team of ultrasound scientists, medical doctors and beauty executives and is currently led by Wayne Wager, CEO. JeNu Biosciences is a Seat...

More Information about "ACEA Biosciences" on BioPortfolio

We have published hundreds of ACEA Biosciences news stories on BioPortfolio along with dozens of ACEA Biosciences Clinical Trials and PubMed Articles about ACEA Biosciences for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ACEA Biosciences Companies in our database. You can also find out about relevant ACEA Biosciences Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Corporate Database Quicklinks

Searches Linking to this Company Record